Wed, May 4, 2022
Tue, May 3, 2022
Mon, May 2, 2022
Sun, May 1, 2022
Fri, April 29, 2022

Joseph Pantginis Maintained (XBIO) at Strong Buy with Decreased Target to $40 on, May 2nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-40-on-may-2nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Pantginis of HC Wainwright & Co., Maintained "Xenetic Biosciences, Inc." (XBIO) at Strong Buy with Decreased Target from $50 to $40 on, May 2nd, 2022.

Joseph, nor any peers, have made any analyst calls on XBIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources